191 related articles for article (PubMed ID: 34355791)
21. Mucosal melanoma of the cranio-facial region: Surgical challenges and therapeutic options.
Thierauf J; Glück AM; Plinkert P; Veit JA; Hoffmann TK; Körber A; Bergmann C
Auris Nasus Larynx; 2019 Apr; 46(2):252-259. PubMed ID: 30082161
[TBL] [Abstract][Full Text] [Related]
22. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
[TBL] [Abstract][Full Text] [Related]
23. Predictors of survival in head and neck mucosal melanoma.
Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS
Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy and overall survival in adult medulloblastoma.
Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB
Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083
[TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.
Haughey BH; Sinha P
Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949
[TBL] [Abstract][Full Text] [Related]
26. Optimal resection margin for head and neck cutaneous melanoma.
Han AY; Dhanjani S; Pettijohn K; Patel PB; John MAS
Laryngoscope; 2019 Jun; 129(6):1386-1394. PubMed ID: 30408184
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Survival Outcomes With/Without Adjuvant Radiation Therapy in Desmoplastic Melanoma.
Lewis GD; Guzman AK; Haque W; McLellan BN; Teh BS
Dermatol Surg; 2021 Oct; 47(10):1333-1336. PubMed ID: 34537788
[TBL] [Abstract][Full Text] [Related]
28. Demographics and treatment trends in sinonasal mucosal melanoma.
Gal TJ; Silver N; Huang B
Laryngoscope; 2011 Sep; 121(9):2026-33. PubMed ID: 22024859
[TBL] [Abstract][Full Text] [Related]
29. Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis.
Chen E; Wu J; Liu Z; Yang S; Wu J; Ouyang P; Xie F
Ann Transl Med; 2021 Mar; 9(5):391. PubMed ID: 33842612
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity.
Mohan S; Pai SI; Bhattacharyya N
Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306
[TBL] [Abstract][Full Text] [Related]
31. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection.
Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT
Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725
[TBL] [Abstract][Full Text] [Related]
32. Real-World Outcomes of Inoperable and Metastatic Cutaneous Head and Neck Melanoma Patients.
Rozendorn N; Shutan I; Feinmesser G; Grynberg S; Hodadov H; Alon E; Asher N
Laryngoscope; 2024 Jun; 134(6):2762-2770. PubMed ID: 38230960
[TBL] [Abstract][Full Text] [Related]
33. Sinonasal mucosal melanoma: A 44-case study and literature analysis.
Dréno M; Georges M; Espitalier F; Ferron C; Charnolé A; Dréno B; Malard O
Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):237-242. PubMed ID: 28442409
[TBL] [Abstract][Full Text] [Related]
34. Postoperative adjuvant radiotherapy improves loco-regional recurrence of head and neck mucosal melanoma.
Wushou A; Hou J; Zhao YJ; Miao XC
J Craniomaxillofac Surg; 2015 May; 43(4):553-8. PubMed ID: 25797388
[TBL] [Abstract][Full Text] [Related]
35. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis.
Ganti A; Raman A; Shay A; Kuhar HN; Auger SR; Patel T; Kuan EC; Diaz AZ; Batra PS; Tajudeen BA
Laryngoscope; 2020 Feb; 130(2):275-282. PubMed ID: 31021415
[TBL] [Abstract][Full Text] [Related]
36. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
37. Clinical characterization and treatment of head and neck mucosal melanoma: a Chilean experience.
Mimica X; Meneses M; Ferrer P; Caglevic C; Cohn D; Lavin M; Marin L; Contreras F
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Sep; 132(3):273-280. PubMed ID: 34088652
[TBL] [Abstract][Full Text] [Related]
38. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
[TBL] [Abstract][Full Text] [Related]
39. Risk-based stratification in head and neck mucosal melanoma.
Moya-Plana A; Mangin D; Dercle L; Taouachi R; Casiraghi O; Ammari S; Nguyen F; Temam S; Robert C; Gorphe P
Oral Oncol; 2019 Oct; 97():44-49. PubMed ID: 31421470
[TBL] [Abstract][Full Text] [Related]
40. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
